KLS-3021, a multifunctional oncolytic virus, demonstrates potent early-intervention efficacy in preclinical models of prostate-confined and locally advanced prostate cancer
These results collectively demonstrate the translational potential of KLS-3021 as a minimally invasive or neoadjuvant therapeutic strategy for prostate cancer, especially in patients for whom early, localized intervention is medically feasible.
Authors
- K. Park
- Jaeil Shin
- Hyesoo Kang
- Soon-Oh Hong
- S. Kim
- Joonsung Kim
- Eunjin Lee (ORCID: https://orcid.org/0000-0001-7553-5630)
- Sungmin Lee
- Jinwon Seo
Institutions
- Kolon Life Science (South Korea) (KR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-13
- DOI
- https://doi.org/10.3389/fonc.2026.1765625
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00